(Q58322700)

English

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination

article by Juliana Cassataro et al published May 2007 in Vaccine

In more languages

Statements

scholarly article

0 references

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination (English)

0 references

1 reference

based on heuristic

inferred from title

Carlos Alberto Fossati

8

object named as

Carlos A. Fossati

0 references

Diego A Laplagne

object named as

Diego A. Laplagne

4

0 references

Karina Alejandra Pasquevich

object named as

Karina A. Pasquevich

2

0 references

Juliana Cassataro

object named as

Juliana Cassataro

1

0 references

author name string

Silvia M. Estein

3

0 references

Carlos A. Velikovsky

5

0 references

Silvia de la Barrera

6

0 references

Raúl Bowden

7

0 references

Guillermo H. Giambartolomei

9

0 references

Fernando A. Goldbaum

10

0 references

language of work or name

0 references

publication date

May 2007

0 references

0 references

25

0 references

22

0 references

4437-4446

0 references

Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

An overview of human brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Epididymitis in rams and lambs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Rough vaccines in animal brucellosis: structural and genetic basis and present status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Brucella melitensis Rev-1 vaccine as a cause of human brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

A polymeric bacterial protein activates dendritic cells via TLR4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

The 18-kDa cytoplasmic protein of Brucella species --an antigen useful for diagnosis--is a lumazine synthase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Identification and partial characterisation of a new protective antigen of Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Selection of protective epitopes for Brucella melitensis by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Immunons revisited: binding of multivalent antigens to B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

The influence of virus structure on antibody responses and virus serotype formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Native-like, long synthetic peptides as components of sub-unit vaccines: practical and theoretical considerations for their use in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.03.028

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58322700&oldid=1550758379"